News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron Variants

Read More

Bio-Europe – November 6-8, 2023 – Munich, Germany

Our CEO Torsten Mummenbrauer is attending #BIOEurope in Munich, November 6-8!
Read More

ExeVir Bio Appoints a Chief Scientific Officer

Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company ...
Read More

ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

Dengue is a mosquito borne viral infection listed by WHO as top 10 threat for global health The government grant is awarded by Flanders Innovation ...
Read More

Bio International Convention – June 5-8, 2023 – Boston, USA

Our CEO and COO are attending this partnering event in person to explore opportunities to collaborate in delivering new medicines to prevent and treat infectious ...
Read More